Enjamb Labs
ActiveAI-nativeWhere drug teams run their entire program, discovery to FDA approval
What it does
Enjamb runs the entire drug program for biopharma teams, from discovery to FDA approval. Pharma runs on decades of closed legacy systems like Benchling, Veeva, Medidata, and SAS, with no AI layer and no MCP to connect agents to them. So we built that connection layer in one platform. Our agents run on top of their existing systems and data, with no migration, and do the work across the whole program: clinical evidence, trial design, statistical programming, and regulatory submissions. In just 3 weeks since launch, we're already being used by 500+ employees at top pharma companies, including Johnson & Johnson, AbbVie, Bristol Myers Squibb, Merck & Sanofi.
Its site says now · captured 2026-08-23
Enjamb: AI Agents for the Full Drug Development Program
Enjamb helps pharma teams synthesize clinical evidence, design trials, run statistical programming, and draft and audit regulatory submissions in one auditable workspace.
Next to it in Vertical AI agents · AI agents for drug development and regulatory submissions
- ApproximaY Combinator W26
Your software should build itself.
- AutoSituY Combinator W26
AI-native workspace for development plan reviews
- CellTypeY Combinator W26
The agentic drug company. We simulate human biology.
- RitivelY Combinator W26
AI-native platform for Life-Sciences Documentation
- ScoopY Combinator F25
Automating regulatory submissions for life sciences
- Adri AIY Combinator W23
Your AI Partner for SAP Development
- EntvinY Combinator S22
Entvin | AI for accelerated Drug Development
- ArdenY Combinator X26
AI-native internal audit firm